Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cytori Cell Research Institute Co., Ltd. (3750:JPX), powered by AI.
Cytori Cell Research Institute Co., Ltd. is currently trading at ¥791. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cytori Cell Research Institute Co., Ltd. on Alpha Lenz.
Cytori Cell Research Institute Co., Ltd.'s P/E ratio is -3.3.
“Cytori Cell Research Institute Co., Ltd. trades at a P/E of -3.3 (undervalued) with modest ROE of -125.1%.”
Ask for details →Cytori Cell Research Institute Co., Ltd. is a biotechnology company primarily committed to the research and development of regenerative medicine. The company's primary focus lies in leveraging the potential of cellular therapies to address a variety of medical conditions. Cytori develops technologies that harness the regenerative capabilities of cells from adipose tissue, providing innovative solutions for a range of applications in healthcare. It impacts sectors such as orthopedics, cardiovascular medicine, and wound care, offering therapies with the potential to revolutionize treatment paradigms. The company also explores collaborations and partnerships to advance the development of cell therapies, ensuring comprehensive coverage from research to clinical application. With a significant presence in the biotechnology sector, Cytori is a pivotal player contributing to the evolution of medical treatments and enhancing the potential for recovery through cellular innovation.
“Cytori Cell Research Institute Co., Ltd. trades at a P/E of -3.3 (undervalued) with modest ROE of -125.1%.”
Ask for details →Cytori Cell Research Institute Co., Ltd. (ticker: 3750) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 10 employees. Market cap is $7.1B.
The current price is 791 with a P/E ratio of -3.34x and P/B of 11.33x.
ROE is -125.10% and operating margin is -660.28%. Annual revenue is $122M.